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Thrombosis is a condition closely related to cerebral aneurysms and controlled
thrombosis is the main purpose of endovascular embolization treatment. The
mechanisms governing thrombus initiation and evolution in cerebral aneurysms have
not been fully elucidated and this presents challenges for interventional planning.
Significant effort has been directed towards developing computational methods
aimed at streamlining the interventional planning process for unruptured cerebral
aneurysm treatment. Included in these methods are computational models of thrombus
development following endovascular device placement. The main challenge with
developing computational models for thrombosis in disease cases is that there exists
a wide body of literature that addresses various aspects of the clotting process, but
it may not be obvious what information is of direct consequence for what modeling
purpose (e.g., for understanding the effect of endovascular therapies). The aim of this
review is to present the information so it will be of benefit to the community attempting
to model cerebral aneurysm thrombosis for interventional planning purposes, in a
simplified yet appropriate manner. The paper begins by explaining current understanding
of physiological coagulation and highlights the documented distinctions between the
physiological process and cerebral aneurysm thrombosis. Clinical observations of
thrombosis following endovascular device placement are then presented. This is followed
by a section detailing the demands placed on computational models developed
for interventional planning. Finally, existing computational models of thrombosis are
presented. This last section begins with description and discussion of physiological
computational clotting models, as they are of immense value in understanding how to
construct a general computational model of clotting. This is then followed by a review of
computational models of clotting in cerebral aneurysms, specifically. Even though some
progress has been made towards computational predictions of thrombosis following
device placement in cerebral aneurysms, many gaps still remain. Answering the key
questions will require the combined efforts of the clinical, experimental and computational
communities.
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INTRODUCTION
The hemostatic process maintains the integrity of the circulatory
system. Under physiological conditions, clotting occurs following
injury to a blood vessel. This overlap of platelet activity and
fibrin formation ensures that bleeding is arrested and initiates
the healing process. In some individuals, the balance between the
procoagulant and anticoagulant processes is disturbed, resulting
in too much clotting or in other cases, insufficient clotting.
There are also pathologies, such as cancers and acute coronary
syndromes, where clotting occurs with no injury to the blood
vessel wall (Ruf and Mueller, 2006; Cimmino et al., 2011).
For both pathologies, clot development has been linked to
circulating forms of tissue factor found on tumor cells or cell-
derived macroparticles. Thrombosis is a biological response
closely linked to cerebral aneurysms, which are balloon-like
dilations of blood vessel walls caused by weakening of the
vessel wall layers (Lawton et al., 2005). In studies covering
populations in the United States, Canada, Europe and Japan, it
was found that cerebral aneurysms have a prevalence of 1–5%
and rupture risk of 0.6% per annum, with 30–50% subsequent
mortality or severe morbidity (Wiebers, 2000; Wermer et al.,
2007). Thrombosis has been observed in both ruptured and
unruptured aneurysms (Eller, 1986; Ishikawa et al., 2006;
Calviere et al., 2011). In unruptured cases, thrombosis can
either stabilize the aneurysm or accelerate the path to rupture.
This is true both for spontaneous clots, which are in the
aneurysm sac with no external input or interference, and for
device-induced clots (Whittle et al., 1982; Byrne et al., 1997,
2010; Vanninen et al., 2003; Cohen et al., 2007). The different
surgical (clips) and endovascular (coils, coils and stent, flow
diverter) treatments that result in device-induced clotting are
illustrated in Figure 1 (Perrone et al., 2015). Given the important
contribution that clots make to aneurysm stability, thrombosis
outcome following device placement could give strong clues
about eventual unruptured aneurysm outcome. The ability
to predict unruptured aneurysm progression is increasingly
important, as advances in medical imaging technology have
increased the number of aneurysms identified accidentally during
routine scans or examinations for other conditions (Rinkel et al.,
1998; Winn et al., 2002; Steiner et al., 2013). The decision
to treat an aneurysm which would otherwise have remained
harmless throughout the life of the patient in question places
an unnecessary burden on healthcare systems and introduces
iatrogenic risks (Wardlaw and White, 2000). Conversely, the
decision not to treat a seemingly asymptomatic aneurysm
may later prove fatal should the aneurysm rupture. Decisions
regarding intervention are made based on morphological
descriptors of the aneurysm. Factors such as size, location, shape,
aspect ratio, and bottleneck factor are considered when deciding
whether treatment is necessary (Wiebers et al., 2003; Morita et al.,
2005; Raghavan et al., 2005; Wiebers, 2005; Wermer et al., 2007;
You et al., 2010).
Owing to the patient-specific nature of cerebral aneurysms,
virtual interventional planning tools capable of predicting
outcome on a personalized basis are highly desirable. Various
computational tools predict the effect of interventional device
placement (Kakalis et al., 2008; Chong et al., 2014; Peach T.
et al., 2014). Often, these tools and models are designed for use
in a patient-specific, interventional planning environment. Many
models focus on predicting the altered hemodynamic conditions
following intervention. A small subset of these have focused
on cerebral aneurysm thrombosis, given that in this particular
pathology, clotting outcome has such a significant impact on
eventual cerebral aneurysm evolution (Ouared et al., 2008; Rayz
et al., 2010; Peach T. W. et al., 2014; De Sousa et al., 2015; Ngoepe
andVentikos, 2016; Ou et al., 2016). The ideal computational tool
would be capable of predicting both the hemodynamic changes
and clot maturation post endovascular device placement, and
would determine the best treatment course for an individual.
Such a tool would also be useful for optimizing anticoagulant
adjunct treatments on a per patient basis.
This review aims to examine the various aspects of thrombus
development in unruptured cerebral aneurysms, with particular
focus on those that are of relevance to developing virtual
interventions. The first part of the review presents and introduces
the mechanisms of cerebral aneurysm thrombosis based on
current understanding of physiological clotting, i.e. desirable
clotting that occurs following injury to a blood vessel. The second
part explores insights gained from clinical observations. The
third part highlights the demands placed on a computational
model of cerebral aneurysm thrombosis if it is to be used
in an interventional planning context. The final part presents
existing computational models of thrombosis and of thrombosis
in cerebral aneurysms. The conclusion then highlights progress
made and future direction.
MECHANISMS OF CEREBRAL ANEURYSM
THROMBUS DEVELOPMENT - BUILDING
UP A FRAMEWORK FROM BIOCHEMISTRY
AND PLATELET BIOLOGY
From a biochemical and platelet biology viewpoint, physiological
clotting is the foundation from which current understanding
of unruptured cerebral aneurysm thrombosis is developed.
The rationale for making use of these physiological models
is explained in the first part of this section, followed by the
similarities and differences between the two processes.
At present, the exact process of cerebral aneurysm thrombosis
is poorly understood. Experimental studies have focused on the
biological processes that unfold after a stable clot has formed
(Bouzeghrane et al., 2010). In vivo observations of clot formation
have proven challenging because of the multiscale nature of
the process (Falati et al., 2002). Given these constraints, it
is necessary to consider the factors that would contribute to
thrombosis in general and to then construct an understanding
of cerebral aneurysm thrombosis from that basis. Virchow
postulated that clotting depends on blood composition, the
state of the vascular endothelium and the local hemodynamics
(Virchow, 1856). It is generally accepted that in cerebral
aneurysms, the main deviations from the physiological state
relate to the state of the vascular endothelium and local
hemodynamics (because of geometric changes) (Stehbens, 1963;
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FIGURE 1 | Surgical and endovascular treatments for cerebral aneurysm thrombosis. (A) Endovascular coiling of the aneurysm sac. (B) Surgical clipping of the
aneurysm neck. (C) Endovascular treatment combining use of coils and a stent. (D) Endovascular treatment with a flow diverter. Taken from Perrone et al. (2015).
Scanarini et al., 1978; Humphrey and Canham, 2000; Rajesh
et al., 2004). There is little evidence to suggest that blood
composition is altered dramatically in this particular pathology,
as aneurysms are more a disease of the blood vessel than of
the blood. For cerebral aneurysm thrombosis, pathways relating
to platelets and coagulation proteins are based on physiological
clotting pathways, which have been thoroughly explored by the
biochemistry community (Davie and Ratnoff, 1964; Macfarlane,
1964; Furie and Furie, 1992; Falati et al., 2002; Hoffman,
2003). The ensuing discussion in this section presents the
putative similarities and key differences between physiological
and cerebral aneurysm clotting pathways. These details are
important in developing a computational cerebral aneurysm
model that moves beyond hemodynamic considerations only.
For both physiological clotting and cerebral aneurysm
thrombosis, clot development is an overlap of spatial and
temporal processes involving platelets, coagulation proteins
and anticoagulant mechanisms. Injury to the vessel wall
results in expression of von Willebrand’s factor (vWF), which
enables platelet attachment to the subendothelial collagen layer
(Sakariassen et al., 1979; Stel et al., 1985). Platelets are recruited
to the site of injury to prevent further blood extravasation
and to facilitate the healing process. Haemodynamics and the
presence of blood cells affect the transport of platelets to the
site of injury and interaction of those platelets with the vessel
wall (Goldsmith and Karino, 1987). Platelet shape changes are
observed during thrombogenesis and the key stages include
deposition, activation, adhesion and aggregation (Kuwahara,
2002). Upon initial contact with the injury zone, platelets take
on a rolling-ball shape and extrude filaments along their surface.
Interactions between the platelet’s receptor GP Ib and vWF
result in a gradual change towards a hemispherical shape. The
same interactions result in firm, reversible adhesion arising from
the activation of the platelet’s integrin αIIbβ3. The interaction
between this activated integrin and vWF results in the formation
of permanent, irreversible bonds. This comes with extensive
spreading of the platelet. Activated platelets can recruit other
platelets to the site of injury and this aggregation results in the
formation of a platelet plug.
A cascade of coagulation reactions occurs alongside platelet
activity, resulting in the formation of a fibrin mesh that secures
the platelet plug in place until healing has occurred. This process
is characterized by clot initiation, and then amplification and
propagation, as seen in Figure 2 (Falati et al., 2002; Hoffman,
2004; Furie and Furie, 2005). The exposure of tissue factor
initiates the reactions and results in the formation of a small
amount of thrombin (Orfeo et al., 2005). During amplification,
this small quantity of thrombin activates platelets and co-factors
V and VIII (Hoffman, 2004). The activation of these cells and
proteins ushers in the propagation phase, which results in the
accelerated production of thrombin and platelet recruitment.
During propagation, some reactions are limited to platelet
membranes, thus regulating and limiting the process to the injury
site (Panteleev et al., 2006). Thrombin is a key protein in clot
development as it acts as an enzyme for the reaction which results
in the formation of fibrin (Mann et al., 2003). It is also responsible
for the activation of platelets and is easily measurable. Tests of
clotting function determine the efficacy of an individual’s clotting
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FIGURE 2 | The initiation and amplification phases of coagulation which result in the formation of thrombin (IIA), an enzyme which catalyses the formation of fibrin. A
coagulation protein circulates in the blood in an inactive state known as a zymogen and contributes to the clotting process once activated. Co-factors amplify and
accelerate the production of activated proteins. They become active in the amplification phase.
mechanism by measuring thrombin. Many of the coagulation
reactions take place on platelet membranes or on subendothelial
cell membranes (Brinkman et al., 1994). Platelets therefore play a
key role not only in filling the gap created by the injury, but also
in supporting some of the enzymatic reactions which result in the
formation of a fibrin mesh (Rosing et al., 1985).
To ensure that clotting is limited to where it is needed only,
both in time and space, several anticoagulant mechanisms limit
the process. These can be seen in Figure 3. The endothelial layer
expresses substances such as nitric oxide, preventing spontaneous
clotting where there is no injury (Bunting et al., 1976; Ignarro
et al., 1987; Cines et al., 1998). In addition, once clotting has taken
place, antithrombin deactivates key proteins such as thrombin,
and tissue factor pathway inhibitor destroys the efficacy of tissue
factor (Seegers et al., 1953; Abildgaard, 1968; Yin et al., 1971;
Damus et al., 1973; Kurachi et al., 1976; Di Scipio et al., 1978;
Rao and Rapaport, 1987).
The key differences between physiological clotting and
thrombosis in cerebral aneurysms relate to initiation. For both
processes, tissue factor must initiate the series of clotting
reactions that result in the formation of a fibrin mesh, however
the source of this tissue factor is thought to differ (Bugge et al.,
1996; Carmeliet et al., 1996; Toomey et al., 1996; Hoffman, 2003,
2004; Hoffman et al., 2006; Mann, 2006; Furie and Furie, 2008;
Morel et al., 2011). In traditional coagulation models, injury to
the vessel wall is necessary for the exposure of subendothelial
tissue factor, which initiates clotting. In cerebral aneurysms,
specifically, the vessel wall is quite compromised with the
endothelium absent for large portions of the sac (Humphrey and
Canham, 2000). Clot initiation has been linked to this endothelial
damage present in the aneurysm sac (Sutherland et al., 1982).
However, fairly recent studies have also verified the presence
of blood-borne tissue factor, a circulating form of the protein
that contributes to the clotting process (Giesen et al., 1999;
Hathcock and Nemerson, 2004; Morel et al., 2006). The exact
role of blood-borne tissue factor in clotting is contested. There
seems to be some consensus that this circulating form of tissue
factor has an influence where there is an abnormal stimulus,
such as increased shear rate (Butenas et al., 2005, 2009; Hoffman
et al., 2006; Mann, 2006; Morel et al., 2006; Okorie et al., 2008).
This is significant for cerebral aneurysms as the condition often
results in complex hemodynamics with varying shear rates. It
has been shown that under flow conditions, adding circulating
tissue factor to blood amplifies the production of fibrin (Okorie
et al., 2008). It would therefore be beneficial to determine the
exact shear rate threshold at which circulating tissue factor
becomes important and to consider this when examining cerebral
aneurysm hemodynamics.
The second key difference relates to the altered pathological
hemodynamics and their effect on platelet activity. In arterial
diseases arising from stenosis, platelets can be activated by
abnormal flow patterns and high shear stresses (Einav, 2004).
Activated platelets can attract other platelets, resulting in the
formation of platelet plugs. The prominence of recirculation
zones common in disease encourages mixing of coagulation
proteins, thus creating an enabling environment for fibrin
formation (Rayz et al., 2008; Di Achille et al., 2014; Peach T. et al.,
2014).
Considering all the contributing factors and gaps in existing
knowledge, it is reasonable to base our initial understanding
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FIGURE 3 | Several anticoagulant mechanisms exist to ensure that clotting is limited to where it is needed. Tissue factor pathway inhibitor (TEFI) inhibits tissue factor,
the protein responsible for clot initiation. Antithrombin targets the activated factors, while activated protein C inhibits the activated co-factors.
of cerebral aneurysm thrombosis on the physiological clotting
process. The platelet and biochemical pathways describing the
latter can therefore be used as a framework for developing a
cerebral aneurysm thrombosis model that accounts for platelet
activity and/or coagulation proteins. The main differences
relate to initiation and clot maturation (Kadirvel et al., 2014;
Gester et al., 2016). The relative contributions of subendothelial
and blood-borne tissue factor must be considered carefully.
In addition, the hemodynamic environment must be well
characterized as disturbances in flow have a significant impact on
platelet activation and protein transport.
INSIGHTS FROM CLINICAL
OBSERVATIONS OF THROMBOSIS IN
CEREBRAL ANEURYSMS
Our current understanding of some of the general features
which are unique to unruptured cerebral aneurysm thrombosis
in humans has been developed from clinical observations. In this
section, observations made following coiling and flow diversion
are presented. Most of the studies included here are those that
were evidence for the American Heart Association/American
Stroke Association “Guidelines for the Management of Patients
With Unruptured Intracranial Aneurysms” (2015) and the
European Stroke Organization “Guidelines for the Management
of Intracranial Aneurysms and Subarachnoid Hemorrhage”
(2013) (Steiner et al., 2013; Thompson et al., 2015). With regards
endovascular treatment, the guidelines focused on coil occlusion
and referred to a few articles on emerging technologies, of which
flow diversion was one. In this section, additional studies were
also considered for flow diversion. Given the relative novelty of
flow diversion as a viable treatment option, the criteria ensured
that the results of the early clinical studies conducted were
included at least once, either directly or in a meta-analysis.
Criteria to include these additional studies (reviews or original
research) were (a) at least nine-hundred unruptured cerebral
aneurysms, (b) treatment with flow diverters, (c) published
between 2013 and 2015 and (d) reporting of occlusion outcome.
Most clinical studies that focus on endovascular treatment infer
clotting outcome from occlusion of the aneurysm sac following
intervention. Clotting is reported as full or partial occlusion
in the two subsections that follow. To conclude this section,
the limitations of using occlusion as a measure of clotting
outcome are discussed and the key clinical questions that relate
to thrombosis in aneurysms following endovascular intervention
are highlighted. The desire to answer these questions has driven
the approaches used when developing computational models for
thrombosis in cerebral aneurysms following device placement.
Coiling in Unruptured Aneurysms
Coiling introduced a paradigm shift in cerebral aneurysm
treatment as it provided a means of occluding the aneurysm
sac with no surgical intervention (Guglielmi et al., 1991). One
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of the earliest studies of thrombus formation following coiling
examined 17 aneurysms removed at autopsy and one removed
after surgery (Bavinzski et al., 1999). It was found that full
occlusion observed at initial angiography did not necessarily
translate into full occlusion at gross pathological examination
following excision. The study also found that unorganized
thrombosis or incomplete clot maturation, i.e., replacement of
the clot with fibrous tissue, could later lead to aneurysm growth
and rupture. The International Study of Unruptured Aneurysm
Investigators then found that for 451 cases, 55% had full
occlusion, 24%were partially occluded and 18% had no occlusion
(Wiebers et al., 2003). A review examined case-fatality, morbidity
and effectiveness in preventing bleeding by enrolling 1,379
patients with at least 1,621 aneurysms (Lanterna et al., 2004). It
was found that none of the aneurysms with full occlusion bled
after embolization with coils. For partially occluded aneurysms,
bleeding was observed in those greater than 10mm in size. A
meta-analysis of 71 studies enrolled 5,044 patients with 5,771
aneurysms (Naggara et al., 2010). One aim of this study was
to estimate treatment efficacy using immediate and follow-up
results. Immediately after treatment, it was found that 86.1% of
aneurysms had full occlusion or a neck remnant only, 10.3% of
aneurysms were partially occluded and that coil treatment was
unsuccessful in 3.6% of cases. During follow-up, recanalization
of the aneurysm sac was observed in 24.4% of patients over
a 0.4–3.2 year period. Finally, the Analysis of Treatment by
Endovascular Approach of Non-ruptured Aneurysms (ATENA)
study enrolled 649 patients with 1,100 aneurysms (Pierot et al.,
2008). It was found that 98.4% were treated with coils alone,
while a few cases required additional techniques, such as stent-
assisted coiling. Following intervention with coils only, 59.0% of
aneurysms had full occlusion, 21.7% had a neck remnant and
19.3%were partially occluded. The studies demonstrated that coil
embolization was an effective mode of treatment for a wide range
of aneurysm cases, but that sometimes, additional techniques
were required. They also demonstrated that full occlusion could
be achieved using coils, and that usually, this led to stability of the
aneurysm sac. A summary of these studies is presented inTable 1.
Flow Diversion in Unruptured Aneurysms
In recent years, flow diverters have gained popularity in treating
large, giant or traditionally untreatable aneurysms (Szikora et al.,
2010). The main principle of flow diverters is that they alter
the local haemodynamics by redirecting flow along the main
vessel and reducing flow into the aneurysm sac (Kulcsár et al.,
2011). The reduced flow in the aneurysm sac often results in
the formation of an occlusive clot. The Pipeline for Uncoilable
or Failed Aneurysms Trial established the efficacy and safety of
the Pipeline endovascular device (Becske et al., 2013). The study
enrolled 108 patients with giant and wide-necked aneurysms. It
was found that flow diverters were an effective means of treating
aneurysms considered difficult to treat using other methods.
After 180 days, it was found that 73.6% of aneurysms were
occluded. One year after treatment, 86.8% of aneurysms had
full occlusion, 5.5% had a neck remnant, 5.5% were partially
occluded and 2.2% had no occlusion. Adverse neurological events
were relatively low (5.6%). A different study published in the
same year established safety and efficacy in Pipeline endovascular
devices and Silk stents (Piano et al., 2013). The study enrolled
101 unruptured aneurysms. Six months after treatment, it was
found that 86% of aneurysms had full occlusion. Of the original
cohort, 53 were evaluated 1 year after intervention. It was found
that none of the aneurysms showed recanalization and complete
shrinkage of the aneurysm sac was evident in 61% of aneurysms
which could be assessed. Mortality andmorbidity rates were both
found to be 3%. As these two studies carried out work to establish
the efficacy and safety of flow diverter placement, various other
hospitals and medical centers in high income countries were
increasingly convinced of flow diversion as a viable alternative
and wanted to better understand the impact of flow diverter use.
Ameta-analysis of 29 studies enrolled 1654 aneurysms and found
complete occlusion in 76% of cases (Brinjikji et al., 2013). When
considering aneurysm size, complete occlusion was observed
in 80% of small aneurysms, 74% of large aneurysms and 76%
of giant aneurysms. Morbidity (5%) and mortality (4%) were
not negligible. The uncertainty about the adverse neurological
outcomes led to a retrospective study in 906 aneurysms (Kallmes
et al., 2015). It was found that neurologic morbidity andmortality
following placement was 8.4%, while spontaneous rupture rate
was 0.6%. Ischemic stroke and intracranial hemorrhage were
2.4% and 4.7%, respectively. In-stent stenosis was observed in
0.3% of cases. Finally, a systematic review of 18 studies with
1704 aneurysms found that average follow-up time was 9 months
(Briganti et al., 2015). At the point defined as “final follow-
up,” complete aneurysm occlusion was observed in 81.5% of
cases. The studies relating to flow diversion demonstrated that
flow diverters were relatively safe and effective for treating
cerebral aneurysms which were difficult to treat with other
endovascular approaches. The occlusion rates following flow
diverter placement were generally high and those aneurysms not
fully occluded postoperatively were often more fully thrombosed
in follow-up observations. The risk of neurologic complication
following flow diverter placement highlighted the importance of
determining when to make use of this mode of treatment. A
summary of these studies is presented in Table 2.
As evidenced by the studies discussed in the last two
subsections, much of the reporting of clotting outcome is inferred
from the extent of occlusion in the aneurysm sac. This is relatively
easy to observe at the end of a procedure as angiography is
already used during intervention (Bederson et al., 2000; Byrne
et al., 2010; Thompson et al., 2015). Even though the extent
of occlusion is thought to indicate re-rupture risk, especially in
ruptured aneurysms, the main challenge with inferring clotting
success from such an indirect measure is that the nature, maturity
and stability of the clot cannot be accounted for (Johnston et al.,
2008). This is, therefore, a very limited assessment when judging
the success of devices as two devices may have similar occlusion
patterns at a given time point, but ultimately lead to very different
thrombus characteristics (Reul et al., 1997; Böcher-Schwarz
et al., 2002). An in vitro study that evaluated flow-diverter
induced thrombosis showed that even when occlusion patterns
were similar for two flow-diverters with different porosities,
the microscopic composition of the clots was not identical
(Gester et al., 2016). The long term stability of the clot is also
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TABLE 1 | Summary of occlusion outcomes for coiling studies.
Study Number of aneurysms Full occlusion (%) Partial occlusion (%) No occlusion (%) Other findings
Bavinzski et al. 18 – – – Full occlusion at initial angiography did not
necessarily translate to longer term
Wiebers et al. 451 55 24 18 Status unknown in 3% of cases
Lanterna et al. 1,621 Full occlusion with coils prevents
rebleeding
Naggara et al. 5,771 86.1 10.3 3.6 Recanalization observed in 24.4% of
cases
Pierot et al. 1,100 59.0 19.3 – Neck remnant in 21.7%
TABLE 2 | Summary of occlusion outcomes for flow diversion studies.
Study Number of aneurysms Full occlusion (%) Partial occlusion (%) No occlusion (%) Other findings
Beckse et al. 108 86.6 5.5 2.2 Neck remnant in 5.5%. Adverse neurological
events in 5.6%.
Piano et al. 101 86 – – Recanalization and shrinkage of sac in 61%.
Mortality and morbidity rates 3%.
Brinjikji et al. 1,654 76 – – 80% in small aneurysms.
74% in large aneurysms.
76% in giant aneurysms.
Kallmes et al. 906 – – – Lowest complication rates observed in small
aneurysms
Briganti et al. 1,704 81.5 – –
influenced by factors not limited to occlusion. Various studies
have shown that thrombus organization and endothelialisation
are more important predictors of long-term outcome following
intervention and occlusion (Bavinzski et al., 1999; Kadirvel et al.,
2014; Szikora et al., 2015).
Even with the insights gained from the above-mentioned
studies, a number of clinical questions relating to endovascular
intervention remain unanswered. The main question that
has driven much of the effort directed towards developing
computational interventional planning tools is when is an
unruptured cerebral aneurysm likely to rupture and therefore,
when should it be treated? Given that the outcome of
intervention is embolization of the aneurysm sac and that this is
thought to influence rupture risk, many tools are now attempting
to answer questions relating to clot growth following device
placement. Ideally, such models should predict immediate and
long-term clotting outcome and stability. They should also enable
optimization of anticoagulant regimens, to avoid undesirable
spontaneous clotting and encourage aneurysm sac embolization
initiated by device placement.
DEMANDS ON COMPUTATIONAL MODELS
OF THROMBOSIS IN CEREBRAL
ANEURYSMS FOR INTERVENTIONAL
PLANNING
For computational models of cerebral aneurysm thrombosis to
be an effective tool in predicting occlusion for interventional
planning purposes, a few considerations must be made. The
models developed must be sophisticated enough to capture
salient details of the occlusion process. They also need to be
simple enough so they can provide information to a clinician
within a reasonable timeframe that is compatible with clinical
routine. In this section, the requirements of interventional
planning and optimization of anticoagulant regimens for
endovascular treatment of cerebral aneurysm are considered.
A discussion of the key outputs from the model, level of
computational burden admissible based on clinical constraints
and level of detail that the model must account for is presented.
This then provides a basis of judgment when considering
different thrombosis modeling techniques and their suitability
for interventional planning.
The key outputs from a computational model of thrombosis
for interventional planning would be an indication of the extent
to which the aneurysm sac is occluded following intervention,
and the time from occlusion to clot maturation. Even though its
focus was on ruptured aneurysms, the CARAT study quantified
risk of rerupture based on occlusion, highlighting the importance
of this factor (Johnston et al., 2008). It was found that rupture
risk was 1.1% for full occlusion, 2.9% for 91–99% occlusion,
5.9% for 70–90% occlusion and 17.6% for <70% occlusion.
Various other studies focusing on unruptured aneurysms have
also highlighted the importance of occlusion outcome following
device placement (Byrne et al., 2010; Saatci et al., 2012; Brinjikji
et al., 2013). For coil embolization, occlusion outcome is
evident immediately after intervention (Pierot et al., 2008).
With flow diverters, occlusion is typically measured over several
months following intervention (Briganti et al., 2015). While
occlusion of the sac is an important clinical endpoint following
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intervention, endothelialisation and thrombus organization are
thought to indicate the long-term stability of the clot and the
aneurysm (Bavinzski et al., 1999; Kadirvel et al., 2014). Predicting
immediate and long-term outcome of clotting would provide
insight into the nature and eventual maturity of the clot, and the
time between occlusion and clot maturity. Such comprehensive
information would be beneficial when selecting a device and
when optimizing adjuvant anticoagulant regimen. In addition,
information about the progression from occlusion to maturity
would provide insight into this critical period that determines
clot stability, and enable the clinician to make adjustments that
would minimize the risk of clot dissolution. The ability to model
such a system computationally would require a well-resolved,
multiscale approach, which could bridge the widely varying
timescales involved. In the flow diverter case, for example,
occlusion may happen within a matter of minutes while clot
maturation may take 6 months (Szikora et al., 2010; Tähtinen
et al., 2012; Heller et al., 2013). The ability to accommodate both
processes within a single framework would be beneficial.
In a clinical setting, turnaround time is an important
factor when considering the applicability of different medical
interventions. Computational models should be designed so the
inputs required can be aligned to existing systems with relative
ease and the outputs can be obtained within reasonable time.
An important input for a computational model of thrombosis
would be magnetic resonance imaging (MRI) or computerized
tomography (CT) scans fromwhich the patient’s aneurysm can be
reconstructed. Even though some studies have shown that three-
dimensional rotational angiography (3DRA) provides higher
anatomical resolution, this modality of imaging would subject
the patient to catheterization during the planning phase (Geers
et al., 2011; Ren et al., 2016). Other key inputs would include
an indication of the pharmacological status and clotting profile
of the patient, and flow rates in the blood vessel of interest. A
study examining the time taken for an intracranial aneurysm to
be coiled found that on average, the mean procedural time from
the first diagnostic angiographic run to the last angiographic run
after embolization was 57.3min (De Gast et al., 2008). Adding
a computational model for interventional planning purposes
would increase the procedural time. For unruptured aneurysms
with no imminent risk of rupture, adding a day or two to
the procedure would be admissible, given the value of the
information that such a model would provide. For unruptured
aneurysms with imminent risk of rupture, procedural time made
lengthier by predictive computational tools could prove fatal
for the patient. The ideal computational model would provide
valuable information within as short a period of time as possible
and minimize the time added to the overall procedural time. The
two key determinants of the level of complexity in the model
are the biochemistry and the local fluid dynamics, and these are
discussed in the two paragraphs that follow.
One of the key inputs for the computational model is the
clotting profile of the patient, representing the biochemical
aspect of coagulation. The ideal input would be a specific
patient’s clotting profile derived from a clinical coagulation test.
Hemker et al. have demonstrated how this can be achieved by
developing a technique that tracks the change in fluorescence of
a fluorogenic thrombin substrate during clot formation in plasma
(Hemker et al., 2000, 2002; Wagenvoord et al., 2006; Hemker and
Kremers, 2013). This signal is then translated into a thrombin
generation curve. The methodology can account for hypo- and
hypercoagulability. Many clotting models have been presented
in literature, with some including all the equations that describe
the clotting process and others presenting a reduced form of the
coagulation process (Hockin et al., 2002; Panteleev et al., 2006;
Wagenvoord et al., 2006; Anand et al., 2008; Filipovic et al., 2008;
Purvis et al., 2008; Xu et al., 2008; Leiderman and Fogelson, 2011;
Storti and Vosse, 2014). The ideal model would incorporate the
minimum number of equations for capturing a unique patient’s
clotting profile. To further simplify the biochemical complexity
in the model, patients could be categorized as hemophiliac,
normal or pro-thrombotic, and this could then reflect in the
model through adjustment of various protein concentrations
and/or clotting equations. Another key aspect that would need
to be incorporated in the model is the effect of anticoagulant
regimens on clotting outcome. Given that the administration
of anticoagulant and antiplatelet therapy is a requirement for
endovascular procedures, the effect of these drugs on the clotting
process must be accounted for and the computational model
could be a tool for optimizing these regimens (Faught et al.,
2014).
The other key input is the local hemodynamics in the region
of clot formation. This is largely influenced by the cerebral
aneurysm geometry, the boundary conditions and the physical
properties of blood. The geometry used to simulate the clotting
process is quite important in predicting occlusion outcome.
Using idealized geometries is too simple to capture the features
unique to specific patients. Over time, a large enough database
of patient cases may be built up so generalized geometries
could be generated from this pool, and these could then give
an accurate enough prediction of clotting outcome. Currently,
patient-specific geometries are still an important part of the
process. A specific patient’s cerebral aneurysm geometry can be
derived from medical images obtained during the diagnostic
stage. Through reconstruction techniques, the scans can be
prepared for computational models (Villa-Uriol et al., 2011). The
boundary conditions applied to the model are a potential area
for simplification. One study has shown that for computational
fluid dynamics (CFD) based rupture predictions, the effect of
flow variability is an important factor to consider and efforts
were made to model boundary conditions more stochastically
to account for uncertainty and variability (Sarrami-Foroushani
et al., 2016). Another potential area for simplification relates
to the physical properties assigned to blood. The properties of
clotted blood differ from those of flowing blood (Diamond, 1999;
Muthard and Diamond, 2012). This needs to be accounted for
in a computational model as regions of clotted blood are likely
to affect the rate at which coagulation proteins are delivered to
the clot site, and the rate at which they react with one another.
Various approaches can be taken to account for this difference in
physical properties and each will have a different computational
cost (Bodnár and Sequeira, 2008; Leiderman and Fogelson, 2011;
Storti and Vosse, 2014). These are discussed in the section that
follows.
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COMPUTATIONAL MODELS OF
THROMBOSIS AND ANEURYSM-SPECIFIC
COMPUTATIONAL MODELS OF
THROMBOSIS
Various computational models of physiological and pathological
clotting have been developed and presented in literature.
These typically consist of different physical subsystems (e.g.,
biochemical reactions, platelets, hemodynamics) that are coupled
together to simulate the clotting process. These subsystems are
referred to as modules in this discussion. Most models are
first developed from a physiological clotting basis which can be
validated and verified. Some of the existing physiological models
could be adapted and developed for computational models
of cerebral aneurysm thrombosis. In this section, we present
existing models found in literature. We begin with general
physiological models and then discuss those designed specifically
for cerebral aneurysm thrombosis.
General Physiological Models
Initially, computational models of the clotting process were
developed to improve understanding of the hemostatic system.
Some models provided a means of coupling various complex
modules and of determining the influence of these subsystems
on the whole system. In this subsection, the different models
are described and grouped according to their foci, namely,
coagulation network models, platelet models, reaction-mass
transport models and integrated models. This is then followed
by a comparison of the different models and their applicability to
patient-specific modeling in cerebral aneurysms.
Coagulation Network Models
Coagulation network models focus solely on the reactions which
result in the formation of thrombin and ultimately, fibrin. These
models are of interest when developing a computational model as
they provide an accessible means of understanding how to model
chemical reactions numerically.
In their work, Hemker et al., Hemker and Kremers, and
Wagenvoord et al. demonstrate a technique for obtaining a
thrombin generation curve from a coagulation test (Hemker
et al., 2000, 2002; Wagenvoord et al., 2006; Hemker and
Kremers, 2013). During clot formation in plasma, the change in
fluorescence of a fluorogenic thrombin substrate is monitored,
and this signal is converted to a thrombin generation curve. An
analytical formula that describes the thrombin generation curve
is presented. Three variables are required to generate a curve
from this formula. These can be obtained from a database of
normal clotting profiles or from an individual patient during
testing. The model presented here would apply to a clinical
setting as the parameters for any patient can be determined with
relative ease. In addition, the model simplifies the computational
cost of incorporating biochemistry.
Butenas et al., Hockin et al., Jones and Mann, and Mann
et al. patented a computer programme that can determine the
efficacy of blood clotting agents (Jones and Mann, 1994; Butenas
et al., 1999; Hockin et al., 2002; Mann et al., 2006). The model
is based on a comprehensive network of the coagulation cascade
and accounts for all the reactions that occur during the clotting
process. It comprises 27 reactions and 42 reaction constants,
and is based on experimental observations. This model accounts
for most of the initiation reactions linked to tissue factor, the
propagation phase and for several inhibitory reactions. The
reactions are expressed as time-dependent partial differential
equations and are computed using a fourth-order Runge-Kutta
solver. This model is the gold standard of comprehensive
computational coagulation cascade models. It would, however,
prove difficult to determine the parameters required for this
model on a per patient basis, in a clinical context.
Platelet Models
The key role played by platelets in coagulation is the central
feature of platelet-centric models. Such models place focus
on the adhesion, activation, accumulation and aggregation of
platelets, and the coagulation reactions supported by the platelet
membranes.
Filipovic et al. developed a two-dimensional model that
considered the interactions between plasma and platelets using
a dissipative particle dynamics (DPD) method (Filipovic et al.,
2008). Blood is considered a colloidal mixture where platelets
and plasma are modeled as mesoscale particles. The movement
of particles is described by Newton’s second law and unlike
the more traditional continuum methods, greater prominence is
given to the contribution of individual particles. These particles
are sufficiently small to track the motion of plasma and platelets,
but are larger than atoms, hence molecular dynamics approaches
were unnecessary for resolving changes in the colloidal system.
The interaction between the particles is described by conservative
(repulsive), dissipative and random (Brownian) forces, and the
model accounts for both active and inactive platelets. The DPD
differential equations are integrated using a velocity Verlet
algorithm. At the end of each time step, the particle’s position
is calculated using the Euler forward method, while the velocity
and forces are calculated using a mid-step velocity. Platelet-
wall adhesion forces are also included in the framework. This is
achieved by incorporating an attraction (bonding) force, which is
modeled as a linear spring attached to the platelet surface on the
one end, and to the wall or an adhered platelet on the other. An
additional parameter relating to the wall domain, which supports
these forces, is also included. The thrombus was seen to grow as
more platelets accumulated, were activated and adhered to the
thrombus mass.
Chatterjee et al. and Purvis et al. presented a model that
can predict all the events that take place during platelet
signaling and includes the activity of both resting and activated
platelets (Purvis et al., 2008; Chatterjee et al., 2010). The model
accounts for molecular mechanisms that accurately describe
platelet homeostasis and response to adenosine diphosphate
(ADP), which activates platelets. Seventy-seven reactions and
seventy species were used to describe the behavior of the human
platelet. Even though the reactions were not exhaustive, the
model accurately reproduced key features of platelet activity,
including intracellular calcium activity. The computational
model was developed from experimental observations, where
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high resolution electron micrographs were used to examine
intracellular calcium concentration in platelets following the
addition of ADP. The reactions in the computational model are
described by ordinary differential equations and are solved in the
Systems Biology Toolbox in MATLAB. Flamm et al. developed
this model further by including the influence of flow and enabling
the prediction of patient-specific platelet network responses
(Flamm et al., 2012). This two-dimensional multiscale model
consists of four submodules. The Lattice Boltzmann submodule
accounts for the flow of the fluid in the solution domain. The
finite element method submodule computes the convection-
diffusion-reaction equations, and accounts for the changing
concentrations of ADP and thromboxane. For this submodule,
the Crank-Nicholson scheme was used for the transient term.
The lattice kinetic Monte Carlo submodule accounts for motion
of individual platelets in the fluid and for platelet interactions
with the surface. Appropriate time steps and event probability
are determined using the Next ReactionMethod. Finally, a neural
network model submodule is used to simulate platelet calcium
signaling and this specific module was customized for each
individual donor.
Several platelet models place emphasis not only on platelet
activation, but also on the adhesion of platelets to other platelets,
and their interactions with the vessel wall. Mody and King
produced a multiscale, three-dimensional model of platelet
adhesion dynamics (Mody and King, 2008a,b). They realized that
much of the existing literature on particulate flows focused on
spherical particles. These models were somewhat inappropriate
for modeling platelet interactions, as active platelets exhibit
filopodia on their surface and inactive platelets resemble flattened
ellipsoids. In their model, hydrodynamic calculations are used
to account for the behavior of platelets, modeled as oblate
spheroids, in a linear shear flow regime. The model couples
two distinct modules. The first module calculates the forces
(gravity, bond, repulsion) acting on individual particles in the
fluid. Special attention is paid to repulsive forces at close range
and their inclusion in the model can account for the interaction
of the platelet with the wall. The second module then computes
the motion of the particles in the fluid, based on the forces
acting on the particle, the external fluid field and rigid body
motion of the particle. This is achieved by numerically solving
the equations of fluid mechanics relating to flows within the
Stokes regime. The integral form of the Stokes equation is solved
using the completed double layer-boundary integral equation
method (CDL-BIEM), a boundary elements method. To validate
the model, collision efficiency calculated using the model was
compared to experimentally-determined efficiency.
Wu et al. developed Mody and King’s approach by modeling
the platelets as deformable particles (Mody and King, 2008a,b;
Wu et al., 2014). The three-dimensional model comprises three
coupled submodules, which account for the elastic properties
of the platelet, flow in the fluid domain and platelet adhesion
kinetics. The platelet elasticity submodule incorporates the
behavior of the cell membrane and the cytoskeleton, and the
flow submodule uses the Lattice Boltzmann method to account
for blood flow. Finally, the adhesion module which accounts for
platelet-platelet adhesion and platelet-vessel wall interactions is
accounted for by a kinetics-based stochastic model. Immersed
boundary methods are used to couple the flow and the platelets,
with the fluid described by an Eulerian approach and the platelets
by a Lagrangian approach. Good agreement was found between
the model’s results and experimental studies carried out by Mody
et al. (2005).
Reaction-Mass Transport Models
Reaction-mass transport models account for coagulation
reactions and the transport of coagulation proteins in the
flowing bloodstream. This enables the investigation of the
effect of convection and/or diffusion on these reactions.
Given the key role played by local hemodynamics in clotting
outcome in aneurysms, these models provide a good basis for
understanding how best to couple biochemical reactions with
local hemodynamics.
In the early nineties, Basmadjian presented a model for
examining the link between flow and chemical reactions
(Basmadjian, 1990). This is achieved by modeling a single,
generic, reaction event at the blood vessel wall. The model
translates in vitro observations of coagulation into mathematical
expressions without oversimplifying the mathematics or
biological events. At the vessel wall, reactions can be modeled as
algebraic equations under steady state conditions and as ordinary
differential equations under transient conditions. The size of
the vessel influences the assumptions which can be made. For
vessels with diameter greater than 0.1mm, radial changes in the
transport resistance and protein concentration are confined to
the boundary layer. Boundary conditions can therefore account
for this variation. For vessels with diameter less than 0.1mm,
that assumption does not hold because the boundary layer is
not thin, relative to the rest of the flow field. Even though this
model is limited to the development of mathematical equations,
it provides good insight into convection-diffusion-reaction
equations and is beneficial for developing a computational
model from first principles.
Panteleev et al. developed mathematical formulae of surface
and volume reactions based on in vitro studies and observations
(Panteleev et al., 2006). The model consists of 27 reactions
and fifty kinetic constants, and describes a reaction-diffusion
system. The computational framework accounts for the different
membranes on which reactions take place (TF-bearing cells and
platelets), and implements updates to protein concentrations
in a biphasic manner. The concentrations of proteins found
on endothelial cells are calculated using surface densities,
while those found on platelet membranes are updated using
volume concentrations. The two phases are linked by boundary
conditions. The differential equations are solved using the
Runge-Kutta-Fehlberg method of the second (third) order
written in a C/C++ compiler.
Bodnar and Sequeira presented a convection-diffusion-
reaction model of coagulation (Bodnár and Sequeira, 2008).
Their computational framework is based on a mathematical
model developed by Anand et al. whose work is presented
in the “Integrated Models” section (Anand et al., 2006, 2008).
The model is implemented in a three-dimensional cylinder
and the coagulation process is described by 23 coupled
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equations that account for reactions and mass transport. A
finite volume solver is used for spatial discretization and
integration is achieved through the use of cell-centered fluxes.
An explicit Runge-Kutta formulation is used for time integration
and pressure stabilization is achieved through the use of an
artificial compressibility approach. The clot and fluid regions are
differentiated by viscosity, which increases linearly with fibrin
concentration. Above a certain fibrin threshold, the viscosity
takes its upper limit value, clearly delineating the clot region. The
upper limit viscosity value is the viscosity of blood multiplied
by a factor of 100. The variation of viscosity is one approach
to accounting for the physical differences between plasma
and clotted blood. In some respects, the model simplifies the
one presented by Anand et al. by considering blood to be
a generalized Newtonian fluid with shear-thinning properties
rather than a viscoelastic material. In addition, platelet reactions
are not modeled directly.
Integrated Models
Integrated models consider the different aspects of clotting.
Often, they incorporate coagulation reactions, platelet activity
and hemodynamics. The benefit of these models is they provide
a mechanism for coupling the different systems that contribute
to the clotting process and are therefore more readily applicable
to interventional planning models. There are pathological cases
where certain aspects of the clotting process may require
alteration, but it is often easier to alter or remove modules than
to develop coupling approaches to include new modules. The
choice of an appropriate integrated model for interventional
planning will depend on the emphasis of that model and on the
computational efficiency of the numerical approach.
Sorenson et al. produced a two-dimensional computational
model of platelet deposition and activation in flowing blood,
with the intention of modeling clot development on biomaterials
(Sorensen et al., 1999a,b). The model accounts for platelet-
platelet and platelet-vessel wall adhesion. The model also
incorporates the role of biochemistry by including ADP,
thromboxane, prothrombin, thrombin and antithrombin. The
changes in the concentrations of the biochemical species and
platelets are described and computed by convection-diffusion-
reaction equations. Fluid flow is described by the Navier-
Stokes equations and contributes to the transport of the
different chemical species. First-order, low-numerical-diffusion-
fluctuation splitting schemes are used to compute the convection
terms and the coupled system is solved using a segregated
iterative procedure. This procedure requires convergence for
each equation and for the entire system. Temporal evolution is
achieved in two steps. The first computes a steady-state solution
in pseudo-time. Advancement of this solution in real-time is
realized in the second step. To validate the computational model,
comparisons are made with experiments where blood flows over
collagen in a parallel plate configuration. It was found that four
parameters were necessary for fitting the computational model
to experimental results. These parameters are shear-dependent
platelet diffusivity and three reaction rate constants dependent
on platelet deposition.
In their mathematical model, Anand et al. tracked the
growth of a clot from initiation to lysis (Anand et al.,
2006). The model accounts for coagulation reactions, platelet
activity and haemodynamics. The biochemical changes that
occur during clotting are described by 23 convection-diffusion-
reaction equations developed from experimental observations.
The initial concentrations of the proteins are those in human
plasma. It is assumed that 0.1% of activated enzymes are
present in the blood. The activity of resting and activated
platelets is also accounted for, with some constants being
taken from literature. The activation of platelets depends on
concentration and on mechanical variables in the flow domain.
Blood is modeled as a viscoelastic fluid with shear-thinning
properties and the constitutive equations for the fluid and
clot regions are similar. The boundary between clot and fluid
can be tracked, making it possible to apply different material
properties, such as viscosity, to different regions. This enables
assignment of different transport properties to proteins in the clot
region, a highly desirable feature in an interventional planning
tool. In a another paper, the same authors consider the case
where blood is static (Anand et al., 2008). This reduced the
complexity of the model by considering a diffusion-reaction
system rather than a convection-diffusion-reaction system, and
enabled validation with experimental results of pooled blood.
The equations are solved using MATLAB’S partial differential
equation solver. In this model, clot growth is observed in
areas where fibrin concentration exceeds a specified threshold
(350 nM) and fibrinolysis takes place where the concentration
drops below this threshold.
Leiderman et al. and Leiderman and Fogelson presented
a two-dimensional computational model accounting for
coagulation reactions, platelet activity and haemodynamics
(Leiderman et al., 2008; Leiderman and Fogelson, 2011, 2013).
The Navier-Stokes equations describe the flow conditions
and the clot region assumes a different porosity value to
plasma. A fractional-step projection method is used to
solve these equations. The evolution of coagulation protein
concentrations are described using partial differential equations,
and distinction is made between those that are found on
platelet membranes, on the subendothelial layers and those
circulating in the bloodstream. In addition, the model accounts
for the altered transport properties of proteins moving within
the clot. Various states of platelet activation are considered
and the molecules which contribute to platelet activation
are represented. The convection of proteins and platelets is
solved using LeVeque’s convection algorithm, while diffusion
is solved using spatial-differencing approximation and Crank-
Nicholson time discretization (LeVeque, 1996). A second-order
Runge-Kutta solver is used to calculate the changes in species
concentration.
In their two-dimensional model, Xu et al. considered the
spatial scales that contribute to the coagulation process (Xu et al.,
2008, 2009a,b). Platelets are microscalar objects and are modeled
using the Cellular Potts method. In this method, the motion of
a platelet is governed by the effective energy of the cell, which
can be calculated using the Metropolis dynamics algorithm.
This module also accounts for platelet-platelet and platelet-vessel
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wall interactions, and for platelet aggregation, adhesion and
activation. Platelet activation occurs once a specified thrombin
threshold is exceeded. The macroscale continuum level accounts
for blood flow, which is described using the Navier Stokes
equations, and for the transport of coagulation proteins. The
biochemical reactions are based on the model developed by
Butenas et al. and are described using partial differential
equations (Butenas et al., 1999). An interface module allows
for smooth transmission of information between the two scales,
which are spatially superimposed. In order to track the interface
between the growing clot and plasma, an algorithm similar to the
volume of fluid method is used. In their updated model, the same
authors implement the model in the venous circulation and treat
the clot as a porous medium (Xu et al., 2010). The role played
by platelet membranes is further developed and each individual
platelet’s contribution to thrombin production is accounted for.
A two-dimensional hybrid dissipative particle dynamics-
partial differential equation (DPD-PDE) model was presented
by Tosenberger et al. (2013). Motion is described by Newton’s
second law and accounts for conservative, dissipative and
random forces between particles. This equation is integrated
using the forward Euler or modified velocity-Verlet algorithm.
Platelets and plasma are modeled using dissipative particle
dynamics. Given that DPD focuses on the mesoscale, each
particle represents a volume of matter rather than an individual
molecule. The radius of all the particles was chosen to match that
of platelets. The changes in fibrin concentration are accounted for
by a partial differential convection-diffusion-reaction equation.
A finite-difference Alternating Direction Implicit method is used
to compute this partial differential equation and the convection
term is treated with a first order upwind scheme. The model
accounts for the changes that occur during clot growth andmakes
a distinction between strongly- and weakly-bound platelets in
the clot mass. In addition, the model differentiates between
platelets covered by fibrin and platelets not covered by fibrin.
This distinction is important as the latter group cannot attach
new platelets.
In their two-dimensional model, Storti et al., and Storti
and Vosse focused on fluid-structure interaction between the
growing platelet mass and blood flow (Storti and Vosse, 2014;
Storti et al., 2014). This model accounts for platelets, the flow
field, biochemical reactions and the mechanical response of the
growing clot. The biochemical model is based on Sorenson
et al.’s framework, which includes active and inactive platelets,
ADP, thromboxane, prothrombin, thrombin and antithrombin
(Sorensen et al., 1999a). The changes in the quantities of
these variables are calculated by a convection-diffusion-reaction
equation. Robin boundary conditions are applied to the injured
part of the vessel, Neumann to the healthy and Dirichlet to
the inlet. One of the key features is a platelet plug growth
model, which is based on the concentration of platelets bound
to the site of injury. This includes platelets bound directly to
the vessel wall, and those bound to other platelets. An Arbitrary
Lagrangian Eulerian method is used to account for the changing
mesh as growth occurs. The interface of the platelet plug is
clearly defined and the plug is a deformable solid which responds
to local haemodynamic changes, which are described by the
Navier-Stokes equations. The non-linear term in the equations
is treated explicitly. A robust fluid-structure solver enables
calculations of the interaction between the platelet plug and local
haemodynamics. This solver operates in a sequential fashion,
where the fluid forces acting on the solid plug are first calculated
and then deformations resulting from the forces are imposed on
the fluid field. This calculation is carried out at every time step
and an implicit Euler method is applied.
Stalker et al. Tomaiuolo et al. and Welsh et al. employed
a systems approach to elucidate the mechanisms at play
during clot formation in arterioles and venules (Stalker et al.,
2014; Tomaiuolo et al., 2014; Welsh et al., 2014, 2016).
Computational and experimental techniques were used to
examine the microenvironment of the clot. Experimental
observations showed that the clot consisted of a core, where
platelets were tightly packed, and a shell, which allowed for
greater diffusion of molecules. Two-dimensional computational
models were developed to examine molecular transport within
this complex structure. In the first model, platelets are modeled
explicitly and are represented as ellipses. This model was used to
examine the effect of packing density and thrombus size on blood
flow velocity. In the secondmodel, the clot is modeled as a porous
medium consisting of two regions. This model also accounts
for species transport, which is described using a convection-
diffusion-reaction equation. Flow in the vessel is described by
Stokes’ equation and flow in the clot by a Brinkman equation.
To account for the different flow properties in the core and shell
regions, different porosity, permeability and effective diffusion
coefficient values are assigned.
Comparison of the Different Approaches and
Applicability to Computational Models of Cerebral
Aneurysm Thrombosis
The biochemical reactions that contribute to the clotting process
are crucial for the formation of fibrin and stabilization of the
platelet mass. Without these reactions, the clotting process is
severely hampered. In developing a computational model of
thrombosis in cerebral aneurysms, it is imperative that these
reactions are included in some form of a biochemistry module.
The main challenge lies in selecting a model that can account
for sufficient detail, while being simple enough for parameters
to be determined within a clinically relevant timeframe. The
work presented by Hemker et al., Hemker and Kremers, and
Wagenvoord et al. would be ideal for a cerebral aneurysm
thrombosis model, as it presents a link between a unique patient’s
thrombin curve and an analytical description which could be
used in the computational model (Hemker et al., 2000, 2002;
Wagenvoord et al., 2006; Hemker and Kremers, 2013). This can
be determined in a clinical test and translated to the model
with relative ease. While the model presented by Hockin et al.
and Mann et al. is a good representation of reality, it contains
far too many rate constants for use in clinic, on a per patient
basis (Hockin et al., 2002; Mann et al., 2006). This model would
be more applicable if one were to consider general population
characteristics which could be pre-programmed, for example,
normal subjects, hemophilia subjects and thrombotic subjects.
Either model could be used for the biochemistry module in
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a cerebral aneurysm thrombosis model. If a model were to
be developed for this specific purpose, it would combine the
simple link between the thrombin curve and a specific patient’s
profile, and the rigor of a model which represents physical reality.
In addition, an improved understanding of cerebral aneurysm
thrombosis biochemistry would enable the development of a
coagulation network that is unique to the pathology.
Including platelets in an interventional planning model would
be beneficial, as it would enable optimization of antiplatelet
therapy administered alongside endovascular device placement.
Several approaches can be taken to include such a module.
The model presented by Chatterjee et al., Flamm et al. and
Purvis et al. is comprehensive in describing platelet signaling
and changes that take place during platelet activation (Purvis
et al., 2008; Chatterjee et al., 2010; Flamm et al., 2012). A
sensitivity study could be carried out to determine the key
reactions, incorporating some of the salient features into an
interventional planning framework. This model is attractive as
it already accounts for patient specificity and could therefore be
used for optimization of antiplatelet therapy with relative ease.
Filipovic et al. couple platelet activity to mass transport through
DPD (Filipovic et al., 2008). The detailed modeling of platelet
behavior is perhaps excessive for a cerebral aneurysm thrombosis
model. The deviation from the usual Navier-Stokes equations
approach does, however, demonstrate a viable alternative when
considering seamless coupling between platelet behavior and
flow. The models presented by Wu et al. and Mody and
King focus on the interactions between individual platelets and
the interaction between platelets and the vessel wall (Mody
and King, 2008a,b; Wu et al., 2014). While these models
accurately capture salient interactions, they could be over-
developed for a cerebral aneurysm thrombosis model. Given the
strong need for feedback within clinically relevant timeframes,
including individual platelet interactions is likely to increase
overall computation time for minimum gain in the final clotting
result.
Reaction-mass transport models are a good alternative to
integrated models. They clearly demonstrate how to couple
the crucial aspects of thrombosis, i.e., local hemodynamics and
reactions (platelets or biochemical). In developing a cerebral
aneurysm thrombosis model, the coupling approaches could
either replicate the models, or they could couple a hemodynamic
method to the biochemical reaction or platelet models described
in the previous two paragraphs. Basmadjian, Panteleev et al., and
Bodnar and Sequeira focus on coupling biochemical reactions
to flow (Basmadjian, 1990; Panteleev et al., 2006; Bodnár and
Sequeira, 2008). The model presented by Basmadjian is helpful
when developing an understanding of how best to implement
boundary conditions in the context of flow. In their reaction-
diffusion model, Panteleev et al. present a further level of
sophistication by distinguishing between biochemical activity at
the vessel wall and activity in blood. Bodnar and Sequeira present
a convection-diffusion-reaction model that can account for the
effect clot on the flow field. This last model could be applied
to a cerebral aneurysm thrombosis model as mass transport is
already coupled to reactions and the numerical approaches have
relatively low computational cost.
Integrated models have robust mechanisms for coupling
different modules. One of the key tasks is determining whether
it is necessary that all these modules are included in the model.
The other major challenge with all the existing integrated models
is that their efficacy has been demonstrated in two-dimensional
geometries. Cerebral aneurysm geometries are often complex,
three-dimensional structures and the transferability of methods
from one dimension to the other would need to be examined.
Sorenson et al. developed one of the earliest integrated models,
which extracted the key equations for platelet activation and
thrombin formation, and coupled these to flow (Sorensen et al.,
1999a,b). The biochemistry/platelet module in this study would
apply to a cerebral aneurysm thrombosis model as it identifies the
key equations and specifies that four parameters are needed to fit
experimental results to computations. These could be determined
with relative ease in a clinical setting, on a per patient basis. The
mathematical model presented by Anand et al. added a level of
sophistication by altering viscosity to account for the effect of
the growing clot on the flow field (Anand et al., 2006, 2008).
The work presented by Bodnar and Sequeira, discussed under the
reaction-mass transport section, implemented a simpler version
of Anand et al.’s work computationally, demonstrating its efficacy
in a three-dimensional geometry (Bodnár and Sequeira, 2008).
Rather than using viscosity, Leiderman et al. and Leiderman and
Fogelson used porosity to account for the effect of the growing
clot in their model (Leiderman et al., 2008; Leiderman and
Fogelson, 2011, 2013). In addition, their model accounts for the
altered transport of biochemical species in the clot region and
for the various states of platelet activation. The models presented
by Sorenson et al. Anand et al. and Leiderman and Fogelson
rely on convection-diffusion-reaction equations for coupling
various entities. Xu et al. take a slightly different approach by
spatially superimposing a microscale platelet model, based on
the Cellular Potts method, with a macroscale flow model (Xu
et al., 2008, 2009a,b, 2010). In addition, they use the volume
of fluid method to carefully track the surface of the growing
clot, making it possible to assign different porosity values to the
region. A combination of Sorenson et al.’s biochemistry module
with Anand et al. or Leiderman et al.’s method for accounting
for the effect of the growing clot on the flow field would apply
to a cerebral aneurysm thrombosis model. Given the complexity
of the aneurysm geometry, the ability to track the surface of
the growing clot in a cerebral aneurysm thrombosis model is
important and the method presented by Xu could be of benefit.
In a similar fashion to Filipovic et al.’s model, discussed under the
reaction-mass transport section, Tosenberger et al. make use of
DPD to account for the interactions between platelets. Themodel
distinguishes between platelets covered by fibrin and those which
are less strongly bound to the clot mass (Filipovic et al., 2008;
Tosenberger et al., 2013). Again, the level of detail in terms of
platelet interactions could be excessive for the aneurysm model,
but the model demonstrates strong coupling between platelet
behavior and fluid transport. Storti et al. and Storti and Vosse
use Sorenson’s model to account for platelet and biochemical
activity (Storti and Vosse, 2014; Storti et al., 2014). Rather than
altering the fluid properties (porosity or viscosity) to account
for the effect of the clot on the flow field, they model the clot
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as a solid mass and define fluid-structure interaction to couple
the behavior of the clot to the flow field. This approach is much
more robust and direct, but may come at a higher cost than
altering fluid properties. Finally, Stalker et al., Tomaiuolo et al.,
and Welsh et al. al make use of a systems biology approach to
develop a model which emphasizes the changes in molecular
transport within the clot region by altering porosity, permeability
and effective diffusivity (Stalker et al., 2014; Tomaiuolo et al.,
2014; Welsh et al., 2014, 2016). Emphasis is also placed on the
core and shell regions of the growing clot. Their experiments
demonstrate the accuracy of this approach and implementation
in a computational model of cerebral aneurysm thrombosis could
be achieved at an acceptable computational cost.
Several models were presented in the preceding discussion.
Integrated models would prove easiest to implement in
cerebral aneurysms, as they describe the clotting process
comprehensively. The greatest setback with these models is
that their level of detail could require significant computational
resources, especially in patient-derived, three-dimensional
geometries. This may not be practical for application in a clinical
context. It would therefore prove worthwhile to carry out a
sensitivity analysis that could establish crucial modules. The
results from such an analysis may show that the simpler models
are adequate for the application at hand. A summary of the
general physiological models can be seen in Table 3.
Cerebral Aneurysm Thrombosis Models
In the previous section, models developed to improve current
understanding of physiological clotting were presented. These
were then compared to each other and assessed for applicability
to a cerebral aneurysm thrombosis model. A fair amount of effort
has been directed at developing cerebral aneurysm thrombosis
models. In this section, these models are presented. With the
exception of one model which makes use of an idealized
geometry, all use realistic, patient-derived aneurysm geometries.
Some modules in these models are borrowed from general
physiological models. These are then coupled to flow and applied
to aneurysm geometries. The different models used are classified
either as thrombosis potential models or as direct thrombosis
models.
Thrombosis Potential Models
Several studies make use of hemodynamic and geometric
variables as surrogate measures for thrombosis potential. With
improved accuracy of computational fluid dynamics methods,
a fair amount of detail can be obtained from patient-specific
simulations. Variables such as aspect ratio, strain rate and
residence time have been studied as potential markers for
thrombus development. These values have been linked to
thrombosed regions in clinical cases. Several models which follow
this approach are presented below.
Sadasivan et al. produced amathematical model that examines
washout from cerebral aneurysms following stent placement
(Sadasivan et al., 2002). The model is based on angiographic
data from an in vitro experiment, and from five patients. The
in vitro experiment made use of an idealized spherical side wall
aneurysm and a pulsatile flow circuit. For both the idealized
TABLE 3 | Summary of the physiological clotting models, illustrating the aspects
of coagulation that each model incorporates.
Model Included features
Biochemistry Haemodynamics Platelet
activation
Clot
mechanobiology
Hemker/
Wagenvoord
et al.
×
Hockin et al. ×
Filipovic et al. × × ×
Chatterjee/Purvis
et al.
× ×
Flamm et al. × × ×
Mody and
King
× ×
Wu et al. × ×
Basmadjian × ×
Pantaleev
et al.
× ×
Anand et al. × ×
Bodnar et al. × × ×
Sorenson
et al.
× × ×
Anand et al. × × × ×
Leiderman
et al.
× × × ×
Xu et al. × × × ×
Tosenberger
et al.
× × × ×
Storti et al. × × × ×
Welsh et al. × × × ×
geometry and patient-derived data, angiography was used to
capture flow within the aneurysm and its surroundings, and
grayscale intensity curves were generated. These results were
then used to develop a mathematical model, and to establish
parameters relating to convective and diffusive transport within
cerebral aneurysms and their parent vessels. The link between
these parameters and stent efficacy was then examined.
Butty et al. presented one of the earliest models that made
use of results from a computational fluid dynamics study to
correlate residence time with thrombosis potential in realistic,
patient-derived cerebral aneurysm geometries (Butty et al., 2002).
In their model, two saccular aneurysms on the right internal
carotid artery are considered. The Navier-Stokes equations are
used to describe flow in the parent artery and in the aneurysm
sac, and a finite volume approach is used to discretize and solve
the governing equations. In order to speed up convergence,
algebraic multigrid acceleration is used. Residence time maps are
constructed based on local flow patterns. The significance of the
residence time profiles was then discussed in light of thrombosis
and pharmacokinetics.
In their studies, Rayz et al. developed the idea presented
by Butty et al. and considered flow residence time and wall
shear stress as potential markers of thrombus prone regions in
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cerebral aneurysms (Butty et al., 2002; Rayz et al., 2008, 2010).
MRI scans were used to reconstruct patient-derived geometries
of cerebral aneurysms. The flow in the aneurysm and parent
vessel is described using the Navier-Stokes equations and a finite
volume approach is used to discretise and solve the equations.
Second-order schemes are employed for spatial and temporal
integration. A PISO scheme is used for pressure-velocity coupling
and an implicit solver is used for solving the Navier-Stokes
equations. A virtual ink technique was developed to monitor
flow residence within the region of interest. A passive scalar
representing the ink is injected at the inlet of the flow regime.
The transport of this “ink” is described and tracked by a
convection-diffusion equation. Comparisons were made between
computational results and MRI scans.
De Sousa et al. presented a model which investigates the
use of geometric and hemodynamic variables as markers for
predicting spontaneous and device-induced thrombus growth in
cerebral aneurysms (De Sousa et al., 2015). The model makes
use of patient-derived cerebral aneurysm geometries segmented
from computed tomography angiography for the spontaneous
thrombosis cases, and digital subtraction angiography data for
the flow diverter cases. To represent the flow diverter within
the geometry, a virtual grid was designed and placed inside the
parent vessel. The Navier-Stokes equations are used to describe
flow in the geometry and a finite volume approach is used to
discretize and solve the governing equations. A PISO scheme
is used for pressure velocity coupling. Comparisons were made
between aneurysm dome to neck ratio, computed strain rate and
clot volumes calculated from scans.
Direct Thrombosis Models
Direct thrombosis models combine local hemodynamics
with other modules described in the physiological clotting
section. Rather than using hemodynamic variables as surrogates
for thrombosis potential, the models directly account for
biochemical and/or platelet activity, and often account for the
impact of the growing clot on the flow field. The models are
detailed below.
Bedekar et al. produced one of the earliest computational
models of cerebral aneurysm thrombosis (Bedekar et al.,
2005). The model accounts for hemodynamics, platelet activity,
coagulation proteins and realistic patient-derived anatomies.
The modules describing coagulation protein reactions and
platelet activity are based on those developed by Sorenson
et al. (Sorensen et al., 1999a,b). The main contribution of
this model is the coupling of the biochemistry and platelet
modules to local hemodynamics in realistic, medical image-
derived vascular segments obtained from computed tomography
scans. The Navier-Stokes equations are used to account for the
hemodynamics in the model and convection-diffusion-reaction
equations are used to calculate the changing concentration of the
platelet and coagulation species. A finite volume scheme is used
to discretize and solve the governing equations. Pressure-velocity
coupling is treated with a SIMPLE-C algorithm and convergence
is sped up using algebraic multigrid acceleration.
Ouared et al. presented a computational model that developed
approaches introduced by thrombosis potential models (Ouared
et al., 2008). The key contribution made by this model was that
the growing clot affected the flow field, and vice versa. Thrombus
growth in the aneurysm sac is governed by a shear regulated
mechanism. Below a shear rate of 100 s−1, clotting is initiated and
growth occurs. A Lattice Boltzmann method for hydrodynamics
is used to compute hemodynamics in an idealized aneurysm
geometry. The method computes forces experienced by fluid
particles in a discrete space-time setup. The particles can move
and collide with each other. The local shear rate is computed
from the equations and clot growth takes place in computational
cells where the shear rate falls below the threshold. The clot
region, once formed, is treated as a no-flow-through solid. Using
a shear rate threshold makes it possible to account for partial
and complete occlusion of the aneurysm sac. The model captures
initiation, growth and cessation of a clot.
Ngoepe and Ventikos and Peach et al. presented a model
that further developed the contributions made by Bedekar
et al. (Bedekar et al., 2005; Peach T. W. et al., 2014; Ngoepe
and Ventikos, 2016). The model accounts for hemodynamics
and biochemical reactions in realistic, patient-derived, cerebral
aneurysm geometries. In addition, the model incorporates flow
diverter placement and the effect of the growing clot on the
flow field, and vice versa. This model is used to predict clotting
outcomes following flow diverter treatment, but highlights the
need for model validation before it could be used in clinical
studies. The Navier Stokes equations account for fluid flow
while convection-diffusion-reaction equations account for the
changes in coagulation protein concentrations. The biochemical
reactions are based on models developed by Hockin et al. and
Wagenvoord et al. and the transport of proteins in the clot region
are altered by an effective diffusivity equation (Hockin et al.,
2002; Wagenvoord et al., 2006). The continuity and momentum
equations are adjusted to incorporate porosity and permeability,
allowing for differentiation between the clot and plasma regions.
A level set method is used to track the surface of the growing
clot. Clot initiation is governed by a shear rate threshold, while
clot growth (tracked by the motion of the surface) is linked to
thrombin concentration.
Ou et al. also developed the framework introduced by Bedekar
et al. and examined fibrin accumulation in cerebral aneurysms
following flow diverter placement (Bedekar et al., 2005; Ou
et al., 2016). They contest that thrombus development in
cerebral aneurysms following flow diverter placement is induced
by stasis and developed a model on that basis. Their model
includes patient-derived aneurysm geometries, hemodynamics,
biochemical equations, the effect of the clot on the flow field,
and flow diverter placement. Navier-Stokes equations are used
account for the local hemodynamics, and blood is modeled as
a non-Newtonian fluid using the Carreau-Yasuda model. The
biochemical equations are based on those developed by Anand
et al. which were developed for static blood (Anand et al., 2008).
These equations are coupled to flow, and convection-diffusion-
reaction equations are used to solve species concentrations.
Porosity and permeability are adjusted to account for the physical
properties of the clot, and to account for the impact of the
growing clot on the flow field and vice versa. A fibrin thresholding
technique is used to distinguish between clotted regions and
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normal plasma. If fibrin exceeds a concentration of 350 nM
in a specific computational cell, the cell assumes properties of
the clot. An experimental rat model was developed to validate
the computational model. The right common carotid artery
was ligated and thrombus formation was observed. Histological
slices were obtained from the experimental model and fibrin
concentration was calculated on each slice. This data was then
used to validate the computational model.
Comparison of Different Approaches Employed in
Developing Computational Models of Cerebral
Aneurysm Thrombosis
Thrombosis potential studies create a link between
hemodynamic variables and thrombus development. An
important step in these studies is the comparison between
computed hemodynamic values and patient-derived data.
In their mathematical model, Sadasivan et al. determined
parameters which could delineate the contributions of
convection and diffusion in patient-derived arteries with
stents (Sadasivan et al., 2002). A direct link was shown between
four of the six parameters and stent efficacy. They suggested
that the altered hemodynamics (e.g., regions of stasis) following
stent placement could indicate high thrombosis potential. At
a similar time, Butty et al. developed a computational model
that examined flow residence time in patient-derived cerebral
aneurysm geometries (Butty et al., 2002). It was found that
particles within close proximity of each other had very different
residence times. This suggested an association between residence
time and thrombosis, even though the link was not clearly
understood. Rayz et al. further examined the role of residence
time in thrombus development, and also considered wall shear
stress as a potential marker (Rayz et al., 2008, 2010). The study
found a correlation between regions of increased residence
time and low wall shear stress on the computational model,
and thrombosis on MRI scans. De Sousa et al. found a strong
association between dome to neck aspect ratio of the aneurysm
and spontaneous clot volume (De Sousa et al., 2015). Areas of
clot growth were also correlated with a strain rate threshold,
below which spontaneous clotting was observed. This work
corroborated the shear rate threshold hypothesis suggested by
Ouared et al. (2008). The ongoing development of thrombosis
potential studies is promising and this approach could be
effective in clinic as it requires fewer patient-specific input
variables and is less computationally expensive when compared
to direct thrombosis approaches.
The combination of hemodynamics and biochemistry in
realistic, patient-derived cerebral aneurysms geometries was
introduced by the work of Bedekar et al. (Bedekar et al.,
2005). Until that point, models developed in realistic geometries
accounted for hemodynamics only, while those that accounted
for the complex biochemistry and platelet environment were
implemented in idealized geometries. Ouared et al. take a
different approach to that employed by Bedekar (Ouared et al.,
2008). The model builds on thrombosis potential models,
however, clot growth is tracked over time and the growing clot
is modeled as a solid, hence it affects the flow field. A shear
rate thresholding technique is used to govern clot initiation,
growth, and cessation. Ngoepe and Ventikos, and Ou et al. build
on Bedekar et al.’s approach by introducing various levels of
sophistication (Ngoepe and Ventikos, 2016; Ou et al., 2016).
The main development presented by both groups was that the
clot had an impact on the flow field, and vice versa. This was
achieved by altering the porosity and permeability in the clot
region. In addition, both groups included device placement (flow
diverters) in the parent vessel. Ou et al. determine clot growth
by a fibrin concentration thresholding technique, while Ngoepe
and Ventikos track the surface of the growing clot by considering
thrombin concentration in a level set method. In the latter model,
clot initiation is governed by a strain rate thresholding technique,
building on the approach introduced by Ouared et al. The major
advantage of Ou et al.’s model is that it has been validated by
studies in an experimental rat model.
Two approaches have been taken when developing
computational models of cerebral aneurysm thrombosis.
The first approach relies heavily on the accurate computation of
hemodynamics within the region of interest. Variables obtained
from these calculations are then used to predict thrombus-prone
regions. The second approach couples the biochemistry of
clotting with hemodynamics and can often account for the
clot growth process. For both approaches, using accurate,
patient-derived aneurysm geometries has proven crucial as the
complexity of the pathology affects local hemodynamics. In
TABLE 4 | Summary of computational cerebral aneurysm thrombosis models, illustrating the aspects of coagulation that each model incorporates.
Model Included features Flow diverter
Biochemistry Haemodynamics Platelet activation Clot mechanobiology Medical imaging
Sadasivan et al. × × ×
Butty et al. × ×
Rayz et al. × ×
Bedekar et al. × × × ×
Ouared et al. × ×
De Sousa et al. × × ×
Ngoepe et al. × × × × ×
Ou et al. × × × × ×
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addition, it has been shown that including flow diverters in the
patient-derived geometries yields different hemodynamic and
clotting results, highlighting the need for accurate modeling
of devices. The main differences between the two approaches
are the ability to capture the temporal evolution of the clot and
the ease of validation of the models. The thrombosis potential
models are likely to predict the same spatial location for clotting
when compared to the direct thrombosis models. If there is
interest in how the clot will progress over time to fill that space,
the direct thrombosis models are likely to have an advantage. The
key consideration when choosing one approach over the other
will be the time point at which one wants to examine clotting.
If determining outcome immediately after device placement is
the main goal, either approach will suffice. If outcome over a
longer time period is desired, then direct thrombosis models
are more suitable as they account for the different stages of
clot development. The main advantage of thrombosis potential
models is that direct validation using existing experimental
techniques is much easier and results are therefore more reliable.
Validation techniques for direct thrombosis models are being
developed but more work is required before these techniques
become routine (Gester et al., 2016). A summary of the cerebral
aneurysm thrombosis models can be seen in Table 4.
CONCLUSIONS
The ideal computational model of thrombosis in cerebral
aneurysms would be capable of predicting occlusion outcome
for a range of endovascular treatments, in a timeframe with the
least impact on overall procedural time. Aneurysm geometries
must be accurately represented as these have a significant
impact on the variation in outcome between different patients.
The model would need to account for the patient’s clotting
profile and would also need to account for the effect of
different treatment regimens. The local hemodynamics also need
to be incorporated into the model. This could be achieved
through suitable boundary conditions and the assignment of
appropriate physical properties to the clot region. Finally, in
as far as is possible, the computational framework would need
to align with existing facilities at healthcare centers focusing
on endovascular treatment of cerebral aneurysms. This would
include compatibility with existing imaging modalities and
coagulation tests.
Though much has been achieved, there are still several
issues to be addressed before the goals described in the
previous paragraph can be achieved. The main areas that
can be strengthened include computation of hemodynamics,
elucidation of the underlying biochemical cascade, clearer
definition of occlusion, inclusion of clot maturation and
modeling of different endovascular interventions. As pertains
to hemodynamics, one of the key areas of focus is developing
boundary conditions that are representative yet computationally
inexpensive. The biochemical cascade that describes cerebral
aneurysm thrombosis has not yet been characterized. Various
suggestions and assumptions have been made but few studies
have focused on elucidating the exact biological mechanisms at
play during the process. Currently, the biochemistry and platelet
biology is based on physiological models of clotting. In vitro
and in vivo studies that establish the exact cascade would be
invaluable. Clinical observations have shown that usually a clot
which occludes the aneurysm sac following the placement of
an endovascular device is most desirable. The clinical studies
reviewed reported occlusion at different levels and at different
time points. It would be beneficial if reporting on occlusion
could be standardized. This would make comparisons between
different devices easier, both in clinic and for in silico models.
Clot maturation is a completely unexplored area in cerebral
aneurysm thrombosis models. Most models can predict the
outcome following intervention but do not account for the
longer term period between occlusion and stabilization. While
post-intervention clotting outcome is a useful metric, it does
not always correlate with longer term stability as the biological
mechanisms that govern the two processes are different. It
would therefore be beneficial if techniques that model the longer
term process were developed. Finally, most models presented
have modeled flow diverter placement. To replicate the choices
available to a clinician, it would be useful if models accounted for
coil embolization and stent-coil combinations. Computational
methods which can account for the deployment of different
endovascular devices and account for their interaction with the
surrounding environment would be of great value. In the long
term, clotting patterns emerging from a large aneurysm database
may make it possible to develop clearer guidelines for device
selection based on aneurysm size and shape.
A review of existing computational models was presented.
First, physiological clotting models were described and discussed
as these often support cerebral aneurysm thrombosis models.
Robust techniques for modeling the clotting process exist.
In addition, many models have presented several approaches
to coupling the different modules that account for in vivo
clotting. Some models present mechanisms for linking results
obtained from clinical tests to mathematical descriptions of
chemical reactions that can be included in an in silico model.
These are highly desirable features as they account for patient
specificity. While integrated models present the highest level
of sophistication, it would be worthwhile establishing whether
all the features included are necessary for predicting occlusion
outcome in a clinical context. Maybe some of the simpler models
strike a better balance between detail and computational cost.
Most of the physiological models have also been implemented
in two-dimensional frameworks only. The extension to three-
dimensions would need to be investigated. Existing cerebral
aneurysm thrombosis models were also presented and discussed.
Two approaches were taken to developing these models, with
one focusing on thrombosis potential and the other on direct
thrombosis modeling. Almost all the models incorporate patient-
derived geometries and complex hemodynamics. Some include
biochemistry and device-placement. At this stage, the models
are computationally expensive and unsuitable for immediate
implementation in clinic. An investigation into the balance
between detail and computational cost would also need to be
carried out for these models. The section exploring demands
placed on clotting models presented various suggestions for
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simplification, such as simplified boundary conditions and
computationally inexpensive methods for representing the
physical properties of the growing clot.
In silico models could be of use in framing some questions
for in vivo and in vitro studies in a quantitative manner. Once
they reach the required level of maturity and robustness, these
models can be used for their original purpose of interventional
planning. Clinicians could determine likely clotting outcomes
for different devices prior to intervention. In addition, device
manufacturers could use an in silico model during the design
process. To make in silico models a suitable design and planning
tool, the basic parameters which capture the salient features
must be determined and computational approaches that
minimize computing time must be employed. The review
has highlighted the indispensability of biochemistry and fluid
dynamics in such models. Once these objectives are achieved,
integrative computational tools of the flavor described promise
to have substantial impact in minimizing complications
and improving clinical outcomes for cerebral aneurysm
healthcare.
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